Characterisation and development of 2448 and C51 : novel monoclonal antibodies targeting ovarian and breast cancer
Monoclonal antibody (mAb) therapy represents an attractive targeted approach for the treatment of cancer. Nevertheless, only a limited number of antigens on solid tumours have been exploited. To address the diverse clinical spectrum of ovarian and breast cancer, the discovery of new antigen targets...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/72381 |